EP1781302A4 - New use - Google Patents

New use

Info

Publication number
EP1781302A4
EP1781302A4 EP05766728A EP05766728A EP1781302A4 EP 1781302 A4 EP1781302 A4 EP 1781302A4 EP 05766728 A EP05766728 A EP 05766728A EP 05766728 A EP05766728 A EP 05766728A EP 1781302 A4 EP1781302 A4 EP 1781302A4
Authority
EP
European Patent Office
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05766728A
Other languages
German (de)
French (fr)
Other versions
EP1781302A1 (en
Inventor
Mona Staahle
Guenther Weber
Johan Heilborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipopeptide AB
Original Assignee
Lipopeptide AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401943A external-priority patent/SE0401943D0/en
Application filed by Lipopeptide AB filed Critical Lipopeptide AB
Publication of EP1781302A1 publication Critical patent/EP1781302A1/en
Publication of EP1781302A4 publication Critical patent/EP1781302A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05766728A 2004-07-28 2005-07-26 New use Withdrawn EP1781302A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59161504P 2004-07-28 2004-07-28
SE0401943A SE0401943D0 (en) 2004-07-28 2004-07-28 New use
PCT/SE2005/001184 WO2006011849A1 (en) 2004-07-28 2005-07-26 New use

Publications (2)

Publication Number Publication Date
EP1781302A1 EP1781302A1 (en) 2007-05-09
EP1781302A4 true EP1781302A4 (en) 2010-02-17

Family

ID=35786492

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05766728A Withdrawn EP1781302A4 (en) 2004-07-28 2005-07-26 New use

Country Status (4)

Country Link
EP (1) EP1781302A4 (en)
AU (1) AU2005267629A1 (en)
CA (1) CA2581693A1 (en)
WO (1) WO2006011849A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2341982B1 (en) 2008-07-14 2012-05-09 Medtronic, Inc. Method for clock management for an implantable medical device
WO2010097774A2 (en) * 2009-02-26 2010-09-02 G-Sense Ltd. Pressurized reservoir system for storing and dispensing liquids
JPWO2016035804A1 (en) * 2014-09-02 2017-07-20 東レ株式会社 Treatment or prevention agent for pruritic skin diseases
US20190183908A1 (en) * 2016-05-13 2019-06-20 Case Western Reserve University Autophagy activators for treating or preventing skin injury
IT202000009388A1 (en) * 2020-04-29 2021-10-29 Steve Jones S R L COMPOSITION FOR TOPICAL APPLICATION WITH ANTIINFLAMMATORY, ANTIMICROBIAL AND REPAIRING ACTIVITIES

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JP2000143515A (en) * 1998-11-16 2000-05-23 Sumitomo Pharmaceut Co Ltd Eczema / dermatitis group treatment
US20010049365A1 (en) * 1998-07-16 2001-12-06 Achkar Charles C. Compositions and methods of treating abnormal cell proliferation
WO2002044403A2 (en) * 2000-11-29 2002-06-06 Mcgill University Markers for testing analogs of vitamin d and therapeutical uses
WO2003018545A1 (en) * 2001-08-22 2003-03-06 Johns Hopkins University 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
JP2004115451A (en) * 2002-09-27 2004-04-15 Noevir Co Ltd Biosynthesis promoter and activity promoter of epidermal transglutaminase
WO2005115403A2 (en) * 2004-05-26 2005-12-08 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494995A4 (en) * 1989-10-04 1993-03-17 Trustees Of Boston University Method of accelerating wound and ulcer healing and treating periodontal disease
US5610978A (en) * 1994-12-30 1997-03-11 Mitel Corporation Ring discriminator
MXPA03003511A (en) * 2000-10-27 2004-05-04 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid.
DE10161729A1 (en) * 2001-12-15 2003-06-18 Mira Ursic Ointment useful for treating e.g. skin wounds, eczema and scars, comprises vitamins, zinc oxide, fish liver oil, lanolin and liquid paraffin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US20010049365A1 (en) * 1998-07-16 2001-12-06 Achkar Charles C. Compositions and methods of treating abnormal cell proliferation
JP2000143515A (en) * 1998-11-16 2000-05-23 Sumitomo Pharmaceut Co Ltd Eczema / dermatitis group treatment
WO2002044403A2 (en) * 2000-11-29 2002-06-06 Mcgill University Markers for testing analogs of vitamin d and therapeutical uses
WO2003018545A1 (en) * 2001-08-22 2003-03-06 Johns Hopkins University 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
JP2004115451A (en) * 2002-09-27 2004-04-15 Noevir Co Ltd Biosynthesis promoter and activity promoter of epidermal transglutaminase
WO2005115403A2 (en) * 2004-05-26 2005-12-08 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200045, Derwent World Patents Index; AN 2000-500665, XP002558645 *
DATABASE WPI Week 200429, Derwent World Patents Index; AN 2004-310753, XP002558646 *
LANSDOWN ALAN B G: "Calcium: A potential central regulator in wound healing in the skin.", WOUND REPAIR AND REGENERATION, vol. 10, no. 5, September 2002 (2002-09-01), pages 271 - 285, XP002558644, ISSN: 1067-1927 *
See also references of WO2006011849A1 *
TIAN X Q ET AL: "1,25-Dihydroxyvitamin D3: A novel agent for enhancing wound healing", JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS INC, US, vol. 59, 1 January 1995 (1995-01-01), pages 53 - 56, XP002459131, ISSN: 0730-2312 *

Also Published As

Publication number Publication date
CA2581693A1 (en) 2006-02-02
AU2005267629A1 (en) 2006-02-02
EP1781302A1 (en) 2007-05-09
WO2006011849A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
GB0522715D0 (en) New use
GB0421908D0 (en) New uses
GB0418540D0 (en) Use
DE502004004685D1 (en) Giessmaschine
GB0407301D0 (en) Use
EP1833808A4 (en) New benzothiazolesulfonamides
GB0417702D0 (en) New uses
GB0410015D0 (en) Use
GB0526552D0 (en) New use
GB0412878D0 (en) Use
GB0419189D0 (en) New uses
GB0424494D0 (en) Use
GB0415178D0 (en) New use
GB0508924D0 (en) New use
GB0408524D0 (en) Use
GB0425061D0 (en) Use
GB0414091D0 (en) Use
IL164525A0 (en) Use
GB0405908D0 (en) Use
GB0418539D0 (en) Use
GB0405907D0 (en) Use
GB0413974D0 (en) Use
GB0404200D0 (en) Use
GB0404201D0 (en) Use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HEILBORN, JOHAN

Inventor name: STAHLE, MONA

Inventor name: WEBER, GUENTHER

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100114

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100413